Milestone. On or before March 31, 2019, enter into a collaboration agreement with a pharmaceutical or biotechnology company that results in aggregate upfront fees in excess of $5,000,000.
Appears in 6 contracts
Samples: Asset Purchase Agreement and Collaboration Agreement (Icagen, Inc.), Asset Purchase Agreement and Collaboration Agreement (Icagen, Inc.), Forbearance Agreement (Icagen, Inc.)